3 August 2026 12:00 AM
Personalized genetic medicines may address unique disease variants, but scientific, regulatory, ethical, and economic barriers remain substantial.
22 July 2026 12:00 AM
An evidence-based overview of how molecular and clinical data can inform diagnosis, treatment selection, risk assessment, and monitoring.